Picture of Biomerieux SA logo

BIM Biomerieux SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-4.39%
3m+0.31%
6m+3.14%
1yr-3.98%
Volume Change (%)
10d/3m+26.3%
Price vs... (%)
52w High-8.07%
50d MA-3.73%
200d MA+2.47%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)22.93
PEG Ratio (f)1.8
EPS Growth (f)14.58%
Dividend Yield (f)1.01%
Valuation (ttm)IndustryMarket
Price to Book Value3.13
Price to Tang. Book4.61
Price to Free Cashflow77.29
Price to Sales3.18
EV to EBITDA15

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital12.03%
Return on Equity10.98%
Operating Margin13.65%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m2,674.83,118.23,376.23,589.13,674.73,944.574,227.28.7%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+5.99+48.43+47.98-24.39-20.64+34.14+11.83n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biomerieux SA EPS forecast chart

Profile Summary

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.

Directors

Last Annual
December 31st, 2023
Last Interim
June 30th, 2024
Incorporated
January 1st, 1967
Public Since
June 7th, 2004
No. of Employees
14,651
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
117,929,352

BIM Share Price Performance

Upcoming Events for BIM

Full Year 2024 Biomerieux SA Earnings Release

Similar to BIM

Picture of AbL Diagnostics SA logo

AbL Diagnostics SA

fr flag iconEuronext - Paris

Picture of Affluent Medical SAS logo

Affluent Medical SAS

fr flag iconEuronext - Paris

Picture of Alpha MOS SA logo

Alpha MOS SA

fr flag iconEuronext - Paris

Picture of Amplitude Surgical SA logo

Amplitude Surgical SA

fr flag iconEuronext - Paris

Picture of Aton SA logo

Aton SA

fr flag iconEuronext - Paris

FAQ